Fibrin fragment D-dimer and the risk of future venous thrombosis.
暂无分享,去创建一个
A. Folsom | W. Rosamond | S. Heckbert | M. Cushman | R. Tracy | Lu Wang | N. Aleksic
[1] A. Folsom,et al. Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. , 2002, Archives of internal medicine.
[2] T. Spector,et al. Activation markers of coagulation and fibrinolysis in twins: heritability of the prethrombotic state , 2002, The Lancet.
[3] R. Tracy,et al. Longitudinal Stability of Coagulation, Fibrinolysis, and Inflammation Factors in Stored Plasma Samples , 2001, Thrombosis and Haemostasis.
[4] J. Danesh,et al. Fibrin D-Dimer and Coronary Heart Disease: Prospective Study and Meta-Analysis , 2001, Circulation.
[5] V. Salomaa,et al. Prospective Study of Fibrinolytic Factors and Incident Coronary Heart Disease: The Atherosclerosis Risk in Communities (ARIC) Study , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[6] J. Hirsh,et al. Fibrinolytic Variables in Patients with Recurrent Venous Thrombosis: a Prospective Cohort Study , 2001, Thrombosis and Haemostasis.
[7] A. Perrier. Deep vein thrombosis and pulmonary embolism: a single disease entity with different risk factors? , 2000, Chest.
[8] M. Woodward,et al. Thrombotic Variables and Risk of Idiopathic Venous Thromboembolism in Women Aged 45-64 Years , 2000, Thrombosis and Haemostasis.
[9] D. Berry,et al. Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] G. Lowe,et al. Prediction of Deep Vein Thrombosis after Elective Hip Replacement Surgery by Preoperative Clinical and Haemostatic Variables: The ECAT DVT Study , 1999, Thrombosis and Haemostasis.
[11] F. Rosendaal. Venous thrombosis: a multicausal disease , 1999, The Lancet.
[12] A. Sharrett,et al. Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[13] L. Kuller,et al. Analytical and biologic variability in measures of hemostasis, fibrinolysis, and inflammation: assessment and implications for epidemiology. , 1999, American journal of epidemiology.
[14] D. Slosman,et al. Non-invasive diagnosis of venous thromboembolism in outpatients , 1999, The Lancet.
[15] P. Reitsma,et al. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. , 1996, Blood.
[16] P. Mannucci,et al. Inherited Thrombophilia: Part 1 , 1996, Thrombosis and Haemostasis.
[17] G. Lowe,et al. Determinants of fibrin D-dimer in the Edinburgh Artery Study. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[18] M. Cushman,et al. Laboratory methods and quality assurance in the Cardiovascular Health Study. , 1995, Clinical chemistry.
[19] P. Ridker,et al. Plasma concentration of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men. , 1994, Circulation.
[20] Pieter H. Reitsma,et al. Mutation in blood coagulation factor V associated with resistance to activated protein C , 1994, Nature.
[21] C. Edwards,et al. D‐dimer: A useful marker of disease stage in surgery for colorectal cancer , 1993, The British journal of surgery.
[22] A. Sharrett. The Atherosclerosis Risk in Communities (ARIC) Study. Introduction and objectives of the hemostasis component. , 1992, Annals of epidemiology.
[23] M. Prins,et al. A critical review of the evidence supporting a relationship between impaired fibrinolytic activity and venous thromboembolism. , 1991, Archives of internal medicine.
[24] R. Kronmal,et al. The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.
[25] K. Wu,et al. ARICHemostasis Study - I. Development of a Blood Collection and Processing System Suitable for Multicenter Hemostatic Studies , 1989, Thrombosis and Haemostasis.
[26] A. Folsom,et al. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. , 1989, American journal of epidemiology.
[27] P. Mombaerts,et al. Fibrinolytic Response and Fibrin Fragment D-Dimer Levels in Patients with Deep Vein Thrombosis , 1987, Thrombosis and Haemostasis.
[28] B. Cosmi,et al. Risk of Venous Thromboembolism Recurrence: High Negative Predictive Value of D-dimer Performed after Oral Anticoagulation Is Stopped , 2002, Thrombosis and Haemostasis.
[29] F. Rosendaal,et al. D-Dimer as a Risk Factor for Deep Vein Thrombosis: The Leiden Thrombophilia Study , 2002, Thrombosis and Haemostasis.
[30] A. Folsom,et al. CHS/ARIC Manuscript Proposal #708 PC Reviewed: 01/06/00 Status: Approved Priority: 2 SC Reviewed: ________ Status: Approved Priority: 2 1a. Title: Cardiovascular risk factors and venous thromboembolism incidence: The Longitudinal Investigation of Thromboembolism Etiology (LITE) Study b. Abbreviated , 2000 .
[31] P. Elwood,et al. Fibrin D-dimer, Tissue Plasminogen Activator, Plasminogen Activator Inhibitor, and the Risk of Major Ischaemic Heart Disease in the Caerphilly Study , 1998, Thrombosis and Haemostasis.
[32] G. Tofler,et al. Hemostatic risk factors for cardiovascular disease , 1996 .
[33] M. Graffar. [Modern epidemiology]. , 1971, Bruxelles medical.